Allergan plc Stock
Your prediction
Pros and Cons of Allergan plc in the next few years
Pros
Cons
Performance of Allergan plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergan plc | - | - | - | - | - | - | - |
| Universal Health Services B | -1.360% | 6.767% | 8.397% | -2.069% | -26.042% | 4.412% | 6.527% |
| HCA Holdings Inc. | 0.260% | 3.867% | 2.345% | 12.573% | -13.307% | 40.750% | 67.482% |
| Quest Diagnostics Inc. | 0.340% | 0.798% | 9.008% | 37.717% | 35.501% | 64.309% | 69.051% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Enact Holdings (ACT) – FY2025 Annual Report
Enact appears to have closed FY2025 in a stable but slightly softer profitability position. Revenue reached roughly $1.24 billion, up modestly from the prior year, while net income of $674 million came in below FY2024's $688 million. The most striking contrast lies not in the operating results but in the stock's valuation: the price-to-earnings multiple appears to have tripled to around 40x, driven by a share price that climbed from roughly $59 to $181 over the year, even as earnings edged lower.
The revenue picture reflects a business whose core premium base has essentially plateaued—premiums earned barely moved year over year—while net investment income has become an increasingly meaningful contributor, rising to $266 million. What stands out most on the profitability side is the sharp increase in losses incurred, which nearly tripled to roughly $110 million. This jump, combined with a growing claims reserve, may suggest a normalization of credit conditions after several unusually benign years, and it appears to be the primary reason margins have continued to compress from the mid-60s percent range in 2022 toward the mid-50s today.
